CPD47, a novel GSK-3β inhibitor, demonstrates antidepressant-like effects via the GSK-3β/β-catenin signaling pathway: Involvement of neurogenesis promotion and neuroinflammation inhibition

作者：Xue-na Gong, Yan-xin Zhou, Chen-yu Wang, Tiantian Wang, Zi-yao Gao, Wen-cai Long, Rong Li, Li Cai · 发表于：International Immunopharmacology · 年份：2025 · DOI：10.1016/j.intimp.2025.116065 · 被引用次数：3 · 研究领域：Wnt/β-catenin signaling in development and cancer、Neurogenesis and neuroplasticity mechanisms、Tryptophan and brain disorders